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Review and proposed diagnostic criteria
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Terry D. Fife, MD
Summary
Mal de débarquement syndrome (MdDS) is a rare
cause of imbalance encountered in a neurology prac-
tice. However, it consists of classic features that the
practicing neurologist should be able to recognize
when evaluating a patient with dizziness. It is charac-
terized by a feeling of rocking and swaying, and typ-
ically follows prolonged exposure to motion, such as
being on a boat or plane. In this review article, we
provide the clinical neurologist with the history of this
disorder followed by illustrative cases of patients
diagnosed with MdDS. Next we present proposed cri-
teria for aiding in diagnosis. Finally, we will discuss a
differential diagnosis for the syndrome, insights into
the possible pathophysiology, current treatments, and
future directions in management.
M
alde débarquement syndrome (MdDS) is not commonly encountered in clinical
practice, but it is a unique cause of dizziness that can often be diagnosed clin-
ically by the astute neurologist. It is characterized by classic features of rocking or
swaying that begin following passive motion exposure, most commonly boat
travel.1 It results in a false perception of self-motion that the individual begins to experience only
upon return to land. MdDS can be either self-limited or persistent; when it is persistent, it may
have less likelihood of resolution. Due to the lack of awareness of this syndrome among
neurologists, patients are often subjected to numerous tests and referrals prior to receiving a
diagnosis. With increased understanding of this syndrome, patients may be more accurately and
efficiently diagnosed by neurologists.
History
MdDS has become increasingly recognized following Brown and Baloh’s 1987 case series
publication of 6 patients with a persistent motion-induced subjective balance disorder. How-
ever, the condition was first described long before then. It was perhaps initially recognized by
Hippocrates, who first described nausea, taken from the root word “naus” or “ship” in the
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Greek language. In his chapter on aphorisms, Hippocrates described his observation that
“sailing on the sea shows that motion disorders the body.”2 A more detailed description was
provided in 1881 by J.A. Irwin, who remarked on “the unsteady gait sometimes observable in
a non-drunken sailor during his first few hours on shore after a long and stormy voyage.”3
Thus, throughout history, MdDS has been recognized time and again as a distinct cause of
imbalance. The name of this syndrome, mal de débarquement, originates from a French term
dating back to 1575 that translates to “sickness of disembarkment.” Disembarking refers to
leaving an aircraft or going ashore after being on a ship. The word “mal” is Latin for “malam,”
which translates to “evil.” And for those who have this syndrome, it can certainly seem like
they are experiencing something evil!
Illustrative cases
Case 1 A 46-year-old woman presented to the neuro-otology clinic with a chief complaint of
dizziness. When asked to describe her dizziness, she responded, “It’s like I’m drunk!” She had
returned from a 7-day Caribbean cruise approximately 1 year prior and had felt off-balance
from the moment she stepped off the ship. She also had felt a constant swaying sensation
since departing from the cruise ship. While on board the ship, she had had no such symp-
toms. Upon disembarking, she had felt as though the ground was moving. This feeling had
not subsided at all for the past year since the cruise ended. She did note that if she was driving
in her car the self-motion perception improved a great deal. However, when she stopped
driving and got out of the car, her disabling symptoms would immediately return. She was
continuing to work as a manager of an electronics store, but she felt that she needed to be
constantly walking around while at work. She preferred not to sit at her desk because her
symptoms worsened when remaining still. She had seen several physicians and undergone
extensive workup including various laboratory studies, brain MRI, videonystagmography
(VNG), and audiogram. All studies were within normal limits. She also had been tried on
medications, including verapamil, nortriptyline, alprazolam, and methylphenidate, none of
which provided any relief. She did find partial relief with diazepam as needed.
Case 2 A 40-year-old woman presented to the neuro-otology clinic for evaluation of “rock-
ing motion.” She had a past history of migraine but no history of seasickness or car sickness.
She related that she had begun feeling the rocking sensation the morning after disembarking
from a 7-day cruise to Puerto Rico almost 6 months earlier. She denied nausea and vomiting.
Hearing was preserved. The rocking sensation was constant but worsened if she remained
still. She tried meclizine, escitalopram, and venlafaxine without any improvement in symp-
toms. She did have mild temporary improvement in symptoms when she took clonazepam.
She tried vestibular therapy but found no relief. She was able to continue working as an
engineer, but she felt as if she was moving all the time. She had a CT of the head, audiogram,
and VNG performed; all of the studies were within normal limits.
Clinical history
MdDS is defined by a persistent perception of self-motion that occurs following a period of
exposure to passive motion.1 This is often seen following an ocean cruise. The syndrome is
more common in women, usually in their 40s.4 The most common triggers are boat and ship
travel, but MdDS can also occur after airplane trips. As was seen in the 2 illustrative cases, the
The differential diagnosis for MdDS includes
other entities such as vestibular migraine,
chronic subjective dizziness, motion sickness,
and various otologic causes of dizziness.
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onset of symptoms is usually immediate after stepping foot on dry land. The symptoms are
variable but all center on the concept of movement despite not actually physically moving.
Common descriptive terms used by patients to describe their symptoms are rocking and
swaying.4 These patients usually do not experience nausea or vomiting and do not feel a sense
of spinning. Hearing is preserved. Patients with MdDS classically report that their symptoms
greatly improve or even dissipate if they are re-exposed to the movement that predated their
symptoms.1,4,5 For example, they feel markedly better if they return to a boat or cruise ship
and get back on board. They also report feeling much better while driving a car. However,
once they stop driving or return to land again, their symptoms not only return but may also
temporarily worsen.4 Typically, MdDS does not persist for an extended period of time. Most
patients experience spontaneous resolution of symptoms within days to several months. As a
result, these patients are not usually the ones presenting to specialty clinics for consultation.
For an unfortunate subset of patients with MdDS, however, the symptoms do not remit
within several months, and these patients may then be classified as having persistent MdDS.
It is much more likely that patients with persistent MdDS will present to a clinic for formal
evaluation. Studies have shown that the longer the duration of symptoms, the less the like-
lihood of resolution.5 It is not uncommon for patients to develop anxiety and/or depression as
a result of their persisting symptoms, especially if they have not been given a definitive
diagnosis yet. Finally, most patients with MdDS report that they have been prescribed
antivertiginous medications for their symptoms but note little relief from any of them.4,6
Diagnosis
Simply put, MdDS remains a clinical diagnosis. The features detailed in the clinical history are
what support the diagnosis of MdDS in a patient. Of these, the most important are a history of
rocking illusory motion following a boat or airplane trip, a relative lack of nausea, and reduction
of symptoms with re-exposure to motion (such as when driving or boating). However, the
workup in a patient complaining of dizziness could potentially include testing such as
VNG, MRI brain, CT temporal bone, audiogram, laboratory studies, or cardiologic evaluation.
The tests vary depending on the clinical presentation of the patient. Testing is useful only in
helping to exclude other disorders that might present with features similar to MdDS. However,
in most classic cases of MdDS, no specific testing is necessary to make the diagnosis. The neu-
rologic examination of a patient with MdDS is notably benign, although patients will convey
that they feel constantly disabled by their symptoms or they might appear hesitant on balance
tests.6 VNG typically shows normal vestibular responses, hearing is normal, and no structural
Table 1 Diagnostic criteria of persistent mal de débarquement syndrome (MdDS)
A. Onset of symptoms after exposure to passive motion,a such as following travel on a boat/cruise
ship or airplane
B. Main symptom is illusory rocking motion
C. Symptoms improve with re-exposure to passive motion, such as boat or car travel
D. Nausea is not a prominent symptom
E. Minimum 3-month duration of symptomsb
F. Not better accounted for by another International Classification of Headache Disorders-3
diagnosis or by another vestibular disorderc
aExposure to passive motion must last at least several hours and more likely will have lasted days.
bA diagnosis of MdDS may still be made with symptoms lasting less than 3 months; however, for a
diagnosis of persistent MdDS symptoms must have lasted at least 3 months.
cHistory and physical do not suggest another vestibular disorder, or another disorder was consid-
ered but ruled out with appropriate testing, or another disorder is present but as an independent
condition with episodes that can be clearly differentiated.21
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abnormalities are found on brain imaging to identify MdDS.1 Table 1 lists proposed diag-
nostic criteria of persistent MdDS.
Differential diagnosis
The differential diagnosis for MdDS includes other entities such as vestibular migraine, chronic
subjective dizziness, motion sickness, and various otologic causes of dizziness. A detailed clinical
history will provide the key to differentiating among each of these (see table 2). Onset of
symptoms in MdDS is typically abrupt and begins soon after disembarking from a ship or
airplane. Persistent MdDS lasts months with spontaneous resolution but can persist for years.
It is not preceded by an infection or other illness. It rarely responds to medications and there
is no definitive diagnostic test.
Vestibular migraine In contrast to MdDS, vestibular migraine often consists of recurrent
vertigo attacks that sometimes but not always include additional symptoms such as headache,
photophobia, phonophobia, or aura. Vestibular migraine is the currently accepted terminology
that replaces past descriptors such as migraine-associated vertigo. Patients may return to normal
in between attacks of vestibular migraine. Onset is not classically triggered by specific events
such as travel or an illness. Vestibular migraine might respond to some of the more common
medications used to treat migraine conditions,7,8 but MdDS usually will not. Nausea is much
more prominent in vestibular migraine.9 Testing is not particularly helpful in differentiating
between the 2, as most often testing is normal in both conditions.
Chronic subjective dizziness This is a term applied to conditions such as panic disorder or
anxiety-related dizziness. The dizziness is sometimes described as rocking, just as with MdDS.
However, it also could be more of a floating or internal spinning sensation.7,10 It is either
constant or occurs in attacks, and dizziness is only one of a myriad of symptoms that might
also include somatic complaints such as weakness, fatigue, gastric distress, and heart palpita-
tions. The symptoms often begin after a period of stress such as a prolonged illness or a death
in the family, and they may last months to years. In contrast, MdDS occurs after passive
motion exposure. Anxiety is common in both patients with chronic subjective dizziness and
those with MdDS, which could make it more likely to get the 2 mixed up.
Motion sickness This results from vestibular or visual stimulation occurring with motion,
and symptoms of dizziness, nausea, vomiting, and sweating are common. Symptoms begin dur-
ing the time of actual motion; this distinguishes it from MdDS, which begins after passive mo-
tion has ended. Medications such as central-acting anticholinergics and H1 antihistamines are
most effective in treating motion sickness,11 but they will not effectively treat MdDS.
Table 2 Comparison of mal de débarquement syndrome (MdDS), vestibular migraine, and anxiety-related dizziness
MdDS Vestibular migraine Anxiety-related dizziness
Onset Abrupt, following boat or
air travel
Spontaneous, or may follow stress or
certain food triggers




Rocking, swaying Spinning, floating, rocking, motion
sensitivity, nausea7,9
Rocking, floating, internal spinning7
Presence of migraine
headaches
Similar to population Often present Similar to population










No response usually Often responds to same medications used
to treat migraine8
May respond to anxiolytics16
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Otologic causes These are easily differentiated from MdDS because they rarely cause the
unending rocking sensation that is so typical of MdDS. Meniere disease is distinguished by
the presence of unilateral muffled and fluctuating hearing with tinnitus, none of which are usu-
ally seen in MdDS since hearing is expected to be normal. Benign paroxysmal positional vertigo
is also easily distinguishable because it is associated with characteristic nystagmus and responds
to canalith repositioning, which has no effect on patients with MdDS. Vestibular neuritis is an
inflammatory condition that presents clinically with a single spontaneous attack of vertigo that
is usually spinning and accompanied by nausea and nystagmus, all features that are unlikely to
be seen in MdDS. VNG testing in vestibular neuritis will show unilateral hypofunction but is
likely to be normal in MdDS. Conditions such as superior canal dehiscence (SCD) and peri-
lymph fistula can cause episodes of vertigo induced by cough or noise causing intracranial or
middle ear pressure changes. They can result in a “third window phenomenon” due to lab-
yrinth defects sometimes caused by trauma or cholesteatoma.12 Hearing tests are usually
abnormal in SCD and perilymph fistula, in contrast to MdDS. A history of airplane travel
triggering symptoms might lead one to consider either perilymph fistula or MdDS, but classic
perilymph fistula presents with a sudden “popping” noise in the ear and is soon followed by
hearing loss, vertigo, and tinnitus.12 Again, MdDS could begin following a history of air travel
but it would not present with hearing changes. Finally, a condition called idiopathic bilateral
vestibular loss can result in dizziness and gait unsteadiness that is worse in darkness. Patients
with this condition can be differentiated from patients with MdDS because they also com-
monly report “bouncing vision” when walking (oscillopsia) and they have reduced vestibular
responses with head impulse testing and quantitative vestibular testing.13,14
Pathophysiology
The pathogenesis of MdDS is not well-understood. A number of theories have been proposed.
One possibility is that MdDS is a disorder of neuroplasticity and more specifically a disorder of
vestibular adaptation.1 When on a boat, the movements consist of roll in combination with
pitch and yaw plane movements.17 The natural adaption to this environment is mediated by
the vestibulo-ocular reflex (VOR) adaptation processes, possibly including velocity storage
mechanisms.18,19 When returning to land, “sea legs” is a common phenomenon.20 A small
number of susceptible individuals may not be able to “turn off” or revert to the prior state of
vestibular adaptation and have a persisting sensation of rocking that is the hallmark of persistent
MdDS.6 If vestibular adaptation and velocity storage are involved, it would imply that indi-
viduals with impaired vestibular function (and thus short VOR time constant values) would not
be susceptible; indeed, most patients with MdDS have normal vestibular function.6
It is also possible that there is a genetic predisposition to MdDS as with motion sickness.11,21
Patients with MdDS and motion sickness both utilize the somatosensory system more than
the vestibular system to maintain balance, so, similar to the theory of motion sickness, MdDS
might result from visual-vestibular conflict as the person is in motion while the visual system
sends signals indicating a stationary environment.
Treatment
There are no effective treatments for MdDS. The resolution of MdDS is spontaneous, so it
often remits without any specific treatment. Most medications for dizziness or motion sickness
MdDS might result from visual-vestibular
conflict as the person is in motion while the
visual system sends signals indicating a
stationary environment.
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such as meclizine, dimenhydrinate, and scopolamine are not useful in MdDS. Anxiolytics may
temporarily improve symptoms, with benzodiazepines likely to provide the most benefit.4
Clonazepam is often preferred due to its longer half-life. Some physicians have found benefit
with the use of selective serotonin reuptake inhibitors as baseline treatment and use benzo-
diazepines only as needed.1 In a recent study, Cha et al. explored the use of repetitive
transcranial magnetic stimulation for MdDS and found overall good tolerability and possible
short-term improvement in rocking sensation reported by participants using a visual analog
scale. Further trials with longer treatment course are needed to support this finding.22 Ves-
tibular rehabilitation has been suggested by some6 as potentially helpful, yet other studies
report no significant response to therapy or exercise.1,4 To date, no randomized controlled
clinical trials of potential treatments for MdDS have been performed.
DISCUSSION
This disorder is largely unrecognized by most physicians treating patients who present with the
symptoms of MdDS, mainly because most clinicians are unaware of the syndrome. Therefore,
increased awareness of MdDS in the medical community is necessary. Macke et al. recently
published a study examining the social, societal, and economic burden of MdDS and found
that the average cost related to obtaining a diagnosis was about $3,000 per patient. They noted
that patients with MdDS report poor overall quality of life and visit no less than 19 physicians
on average before receiving a diagnosis.23 Currently, most patients with MdDS are diagnosed
after consultation with one of a small number of specialists in our country that are familiar
with the disorder. This often does not take place until months after the patient’s onset of
symptoms and numerous referrals have been made. With increased awareness of MdDS,
patients could be diagnosed at an earlier stage and could bypass extensive medical testing
and multiple physician referrals. Earlier diagnosis would also help reduce the anxiety these
patients experience as a result of not knowing the cause of their unrelenting symptoms. In
terms of treatment, there is no first-line treatment recommendation for MdDS. New poten-
tial treatments such as repetitive transcranial magnetic stimulation, certain vestibular therapy
exercises, or pharmacotherapy may prove useful, but more trials are needed before any strong
conclusions can be made.
REFERENCES
1. Cha YH. Mal de Debarquement. Semin Neurol 2009;29:520–527.
2. Adams F. The genuine works of Hippocrates translated from the Greek. Syndenham Soc 1822;2:725.
3. Irwin JA. The pathology of sea-sickness. Lancet 1881;2:907–909.
4. Hain TC, Hanna PA, Rheinberger MA. Mal de Debarquement. Arch Otolaryngol Head Neck Surg
1999;125:615–620.
5. Cha Y-H, Brodsky J, Ishiyama G, Sabatti C, Baloh RW. Clinical features and associated syndromes of
mal de debarquement. J Neurol 2008;255:1038–1044.
6. Brown JJ, Baloh RW. Persistent mal de debarquement: a motion-induced subjective disorder of
balance. Am J Otolaryngol 1987;8:219–222.
7. Fife TD. Migraine associated vertigo: a common but difficult-to-define disorder. Pract Neurol 2009;9:
27–33.
8. Lempert T. Vestibular migraine. Semin Neurol 2013;33:212–218.
9. Lempert T, Olesen J, Furman J, et al. Vestibular migraine: diagnostic criteria. J Vestib Res 2012;22:
167–172.
10. Staab JP, Balaban CD, Furman JM. Threat assessment and locomotion: clinical applications of an
integrated model of anxiety and postural control. Semin Neurol 2013;33:297–306.
11. Shupak A, Gordon CR. Motion sickness: Advances in pathogenesis, prediction, prevention, and
treatment. Aviat Space Environ Med 2006;77:1213–1223.
12. Hathiram BT, Khattar VS. A third labyrinthine window: an overview of perilymph and labyrinthine
fistulae and superior semicircular canal dehiscence. Otorhinolaryngol Clin Int J 2012;4:100.
13. Baloh RW, Jacobson K, Honrubia V. Idiopathic bilateral vestibulopathy. Neurology 1989;39:272–275.
14. Hain TC, Cherchi M, Yacovino DA. Bilateral vestibular loss. Semin Neurol 2013;33:195–203.
15. Cass SP, Furman JM, Ankerstjerne JP, Balaban C, Yetiser S, Aydogan B. Migraine-related vestibu-
lopathy. Ann Otol Rhinol Laryngol 1997;106:182–189.
214 © 2015 American Academy of Neurology
Kamala C. Saha and Terry D. Fife
ª 2015 American Academy of Neurology. Unauthorized reproduction of this article is prohibited.
16. Ruckenstein MJ, Staab JP. Chronic subjective dizziness. Otolaryngol Clin North Am 2009;42:71–77.
17. Schmitke RT. Ship sway, roll and yaw motions in oblique seas. SNAME Transactions 1978;86:26–46.
18. Cohen H, Cohen B, Raphan T, Waespe W. Habituation and adaptation of the vestibuloocular reflex:
a model of differential control by the vestibulocerebellum. Exp Brain Res 1992;90:526–538.
19. Raphan T, Cohen B. The vestibulo-ocular reflex (VOR) in three dimensions. Exp Brain Res 2002;
145:1–27.
20. Gordon CR, Spitzer O, Shupak A, Doweck I. Survey of mal de debarquement. BMJ 1992;304:544.
21. Reavley CM, Golding JF, Cherkas LF, Spector TD, MacGregor AJ. Genetic influences on motion
sickness susceptibility in adult women: a classical twin study. Aviat Space Environ Med 2006;77:
1148–1152.
22. Cha Y-H, Cui Y, Baloh RW. Repetitive transcranial magnetic stimulation for mal de debarquement
syndrome. Otol Neurotol 2013;34:175–179.
23. Macke A, LePorte A, Clark BC. Social, societal, and economic burden of mal de debarquement
syndrome. J Neurol 2012;259:1326–1330.
STUDY FUNDING
No targeted funding reported.
DISCLOSURES
The authors report no disclosures. Full disclosure form information provided by the authors is available
with the full text of this article at Neurology.org/cp.
Related articles from AAN physician and patient resources
Neurologyw Clinical Practice
The evaluation of a patient with dizziness
December 2011;1:24–33.









Neurology Noww C Neurologynow.com
Take a Stand: A neurologic disorder known as POTS causes dizziness and fainting—and
frustration, due to lack of awareness and inadequate treatment
February/March 2015;11:44–47.
Neurology Todayw C Neurotodayonline.com
UP&COMING: Kevin Kerber, MD: On Improving Care and Reducing Cost for BPPV
Treatment in the ER
February 20, 2014;14:21–22.
Neurology: Clinical Practice ||| June 2015 Neurology.org/cp 215
Mal de débarquement syndrome
ª 2015 American Academy of Neurology. Unauthorized reproduction of this article is prohibited.
